Inocoterone acetate

From WikiMD's Medical Encyclopedia

Revision as of 23:53, 24 February 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Overview of the antiandrogen drug Inocoterone acetate


Inocoterone acetate
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG


Inocoterone acetate is a nonsteroidal antiandrogen (NSAA) that was developed for the treatment of androgen-dependent conditions such as acne, androgenic alopecia, and hirsutism. It is a topical medication that acts by blocking the effects of androgens like testosterone and dihydrotestosterone (DHT) in the skin.

Mechanism of Action

Inocoterone acetate works by competitively inhibiting the binding of androgens to the androgen receptors in the skin. This prevents the activation of androgen receptors by testosterone and DHT, thereby reducing the effects of these hormones on target tissues. As a result, the growth of sebaceous glands and hair follicles is reduced, which helps in managing conditions like acne and hirsutism.

Pharmacokinetics

Inocoterone acetate is applied topically, and its absorption through the skin is minimal. This localized application helps in reducing systemic side effects that are commonly associated with oral antiandrogens. The drug is metabolized in the skin to its active form, inocoterone, which then exerts its antiandrogenic effects.

Clinical Use

Inocoterone acetate has been primarily investigated for use in treating acne and hirsutism. Its efficacy in reducing acne lesions and hair growth has been demonstrated in clinical trials, although it is not as widely used as other treatments like spironolactone or finasteride.

Side Effects

The side effects of inocoterone acetate are generally mild due to its topical application. Some patients may experience local skin irritation, redness, or dryness at the site of application. Unlike systemic antiandrogens, it does not cause significant hormonal changes in the body.

Development and Availability

Inocoterone acetate was developed in the 1990s, but it has not been widely marketed or approved for use in many countries. Its development was primarily focused on providing a topical alternative to systemic antiandrogens for dermatological conditions.

Related pages

Inocoterone_acetate

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.